Squarepoint Ops LLC Corcept Therapeutics Inc Transaction History

Squarepoint Ops LLC

$62.8 Billion
Q3 2024

A detailed history of Squarepoint Ops LLC transactions in Corcept Therapeutics Inc stock. As of the latest transaction made, Squarepoint Ops LLC holds 28,500 shares of CORT stock, worth $1.64 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

28,500

Holding current value

$1.64 Million

% of portfolio

0.0%

24 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 15, 2024	SELL	$21.1 - $27.46 $643,634 - $837,639	-30,504 Reduced 40.94%	44,007 $1.11 Million
Q4 2023 Feb 14, 2024	SELL	$24.82 - $32.88 $155,100 - $205,467	-6,249 Reduced 7.74%	74,511 $2.42 Million
Q2 2023 Aug 14, 2023	BUY	$21.44 - $25.15 $1.73 Million - $2.03 Million	80,760 New	80,760 $1.8 Million
Q4 2022 Feb 14, 2023	SELL	$19.95 - $29.96 $218,592 - $328,271	-10,957 Reduced 32.63%	22,627 $459,000
Q3 2022 Nov 14, 2022	SELL	$24.7 - $29.12 $698,046 - $822,960	-28,261 Reduced 45.7%	33,584 $861,000
Q2 2022 Aug 15, 2022	SELL	$17.33 - $25.3 $881,213 - $1.29 Million	-50,849 Reduced 45.12%	61,845 $1.47 Million
Q1 2022 May 16, 2022	BUY	$16.53 - $25.21 $674,407 - $1.03 Million	40,799 Added 56.75%	112,694 $2.54 Million
Q4 2021 Feb 14, 2022	BUY	$17.1 - $23.34 $1.01 Million - $1.38 Million	59,285 Added 470.14%	71,895 $1.42 Million
Q3 2021 Nov 15, 2021	BUY	$19.68 - $22.53 $248,164 - $284,103	12,610 New	12,610 $248,000
Q1 2021 May 17, 2021	SELL	$23.49 - $30.56 $1.49 Million - $1.94 Million	-63,448 Closed	0 $0
Q4 2020 Feb 16, 2021	BUY	$16.78 - $27.3 $1.06 Million - $1.73 Million	63,448 New	63,448 $1.66 Million
Q3 2020 Nov 16, 2020	SELL	$12.46 - $19.98 $225,687 - $361,897	-18,113 Closed	0 $0
Q2 2020 Aug 14, 2020	SELL	$11.0 - $18.26 $516,043 - $856,631	-46,913 Reduced 72.14%	18,113 $305,000
Q1 2020 May 15, 2020	BUY	$10.11 - $14.04 $657,412 - $912,965	65,026 New	65,026 $773,000
Q4 2019 Feb 14, 2020	SELL	$12.06 - $16.96 $297,845 - $418,861	-24,697 Closed	0 $0
Q3 2019 Nov 14, 2019	SELL	$10.41 - $14.66 $1.55 Million - $2.18 Million	-148,674 Reduced 85.75%	24,697 $349,000
Q2 2019 Aug 14, 2019	BUY	$9.78 - $12.76 $291,326 - $380,094	29,788 Added 20.75%	173,371 $1.93 Million
Q1 2019 May 15, 2019	BUY	$10.03 - $15.71 $321,401 - $503,411	32,044 Added 28.73%	143,583 $1.69 Million
Q4 2018 Feb 14, 2019	BUY	$11.29 - $17.19 $1.26 Million - $1.92 Million	111,539 New	111,539 $1.49 Million
Q3 2018 Nov 14, 2018	SELL	$12.27 - $15.65 $711,623 - $907,653	-57,997 Closed	0 $0
Q2 2018 Aug 14, 2018	SELL	$15.3 - $19.69 $4.12 Million - $5.31 Million	-269,594 Reduced 82.3%	57,997 $912,000
Q1 2018 May 15, 2018	BUY	$14.59 - $25.5 $4.35 Million - $7.6 Million	297,864 Added 1002.0%	327,591 $5.39 Million
Q4 2017 Feb 14, 2018	BUY	$15.77 - $20.72 $65,697 - $86,319	4,166 Added 16.3%	29,727 $537,000
Q3 2017 Nov 14, 2017	BUY	$12.3 - $19.3 $314,400 - $493,327	25,561	25,561 $493,000

Others Institutions Holding CORT

# of Institutions

347

Shares Held

86.6M

Call Options Held

1.12M

Put Options Held

667K

View Full List

About CORCEPT THERAPEUTICS INC

Ticker CORT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 107,105,000
Market Cap $6.16B
Description
Corcept Therapeutics Incorporated discovers, develops, and commercializes drugs for the treatment of severe metabolic, oncologic, and neuropsychiatric disorders in the United States. The company offers Korlym (mifepristone) tablets as a once-daily oral medication for the treatment of hyperglycemia secondary to hypercortisolism in adult patients ...

More about CORT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Squarepoint Ops LLC, based on Form 13F filings with the SEC.

News

Stay updated on Squarepoint Ops LLC with notifications on news.

Account

Squarepoint Ops LLC Corcept Therapeutics Inc Transaction History